JPRN-UMIN000024969已完成未知
Two-way crossover comparison of tofogliflozin and canagliflozin using continuous glucose monitoring. - Two-way crossover comparison of tofogliflozin and canagliflozin using continuous glucose monitoring.
Kitasato University School of Pharmacy0 个研究点目标入组 20 人开始时间: 2016年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with diabetic nephropathy more than stage 3 (urinary albumin 300mg/gCr or urinary protein 0.5g/gCr) or with abnormal aspartate aminotransferase/alanine aminotransferase elevation (3 X the upper limit of normal) were excluded from this study.
研究者
相似试验
招募中
不适用
Direct comparison of TOfogliflozin and iPragliflozin on hyper-hypoglycemia using Continuous Glucose Monitoring system (TOP-CGM)Type 2 diabetesJPRN-UMIN000018265niversity of Occupational and Environmental Health30
已完成
不适用
Comparison of safety and efficacy of Tofogliflozin and Ipragliflozin in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000037158Minami Osaka hospital24
未知
1 期
Drug-drug interaction study (2) of TofoglifloziJPRN-jRCT2080221710Chugai Pharmaceutical Co., Ltd.87
已完成
不适用
Tofogliflozin And Empagliflozin Cross-over TrIal(TACTICS)JPRN-jRCTs031190021Yamada Yoshihiko56
招募中
4 期
Effect of tofogliflozin on pancreatic beta-cell functioType 2 diabetesJPRN-jRCTs011230006akamura Akinobu70